Literature DB >> 12960688

Role of nitric oxide in the renal protective effects of ischemic preconditioning.

Junji Yamashita1, Masaya Ogata, Makoto Itoh, Hiroshi Yamasowa, Yuka Shimeda, Masanori Takaoka, Yasuo Matsumura.   

Abstract

Possible involvement of nitric oxide (NO) in the protective effect of ischemic preconditioning against the ischemia/reperfusion-induced acute renal failure was investigated. Ischemic preconditioning, which consists of three cycles of 2-minute ischemia followed by 5-minute reperfusion, was performed prior to 45-minute ischemia. Ischemic preconditioning significantly improved the renal dysfunction induced by 45-minute ischemia followed by 24-hour reperfusion. Histopathological examination of the kidney of ischemia/reperfusion rats revealed severe renal damage, and suppression of the damage was seen with the ischemic preconditioning treatment. NO metabolites (NOx) production in the kidney after 45-minute ischemia and reperfusion was markedly increased in ischemia/reperfusion rats with ischemic preconditioning, compared with animals not subjected to ischemic preconditioning, and these increases correlated with changes in endothelial NO synthase (eNOS) protein expression in renal tissues. The improvement of renal dysfunction in ischemic preconditioning rats was abolished by the pretreatment with NG-nitro-L-arginine, a nonselective NOS inhibitor, but not with aminoguanidine, an inducible NOS inhibitor. In addition, increment of endothelin-1 (ET-1) content in the kidney after the reperfusion was markedly suppressed by ischemic preconditioning treatment. These findings suggest that the protective effect of ischemic preconditioning on ischemia/reperfusion -induced acute renal failure is closely related to the renal nitric oxide production following the increase in eNOS expression after the reperfusion and that the suppressive effect of ischemic preconditioning on the ischemia/reperfusion -induced renal ET-1 overproduction may be partly involved in the ameliorating effect of ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960688     DOI: 10.1097/00005344-200309000-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury.

Authors:  Michael S Forbes; Barbara A Thornhill; Matthew H Park; Robert L Chevalier
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 2.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

3.  The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats.

Authors:  Hong-Gang Zhao; Xiao-Cai Sun; Xiao-Hui Xian; Wen-Bin Li; Min Zhang; Qing-Jun Li
Journal:  Neurochem Res       Date:  2007-06-06       Impact factor: 3.996

4.  Hyperglycemia abolishes the protective effect of ischemic preconditioning in glomerular endothelial cells in vitro.

Authors:  Katie J Schenning; Sharon Anderson; Nabil J Alkayed; Michael P Hutchens
Journal:  Physiol Rep       Date:  2015-03

5.  Remote ischemic perconditioning attenuates ischemia/reperfusion-induced downregulation of AQP2 in rat kidney.

Authors:  Marie Louise V Kristensen; Casper Kierulf-Lassen; Per Mose Nielsen; Søren Krag; Henrik Birn; Lene N Nejsum; Rikke Nørregaard
Journal:  Physiol Rep       Date:  2016-07

6.  Hepatic ischemic preconditioning provides protection against distant renal ischemia and reperfusion injury in mice.

Authors:  Jung Ah Lee; Jin Woo Choi; Jang Hyeok In; Hong Soo Jung; Yong Shin Kim; Yeon Soo Jeon; Yoo Jin Kang; Dae Woo Kim; Yong Gul Lim; Jae Hee Park; Jin Deok Joo
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

7.  Renal lesions in leptin receptor-deficient medaka (Oryzias latipes).

Authors:  Shinichi Chisada; Akihiko Sugiyama
Journal:  J Toxicol Pathol       Date:  2019-06-10       Impact factor: 1.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.